168 related articles for article (PubMed ID: 32375225)
41. Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with Gram-negative bacteremia.
Micek ST; Welch EC; Khan J; Pervez M; Doherty JA; Reichley RM; Hoppe-Bauer J; Dunne WM; Kollef MH
J Hosp Med; 2011 Sep; 6(7):405-10. PubMed ID: 21916003
[TBL] [Abstract][Full Text] [Related]
42. Cloning, characterization and comparison of the Pseudomonas mendocina polyhydroxyalkanoate synthases Phac1 and PhaC2.
Hein S; Paletta JR; Steinbüchel A
Appl Microbiol Biotechnol; 2002 Feb; 58(2):229-36. PubMed ID: 11878309
[TBL] [Abstract][Full Text] [Related]
43. Epidemiology and Microbiology of Skin and Soft Tissue Infections: Preliminary Results of a National Registry.
Esposito S; De Simone G; Pan A; Brambilla P; Gattuso G; Mastroianni C; Kertusha B; Contini C; Massoli L; Francisci D; Priante G; Libanore M; Bicocchi R; Borgia G; Maraolo AE; Brugnaro P; Panese S; Calabresi A; Amendola G; Savalli F; Geraci C; Tedesco A; Fossati S; Carretta A; Santantonio T; Cenderello G; Crisalli MP; Schiaroli E; Rovere P; Masini G; Ferretto R; Cascio A; Colomba C; Gioè C; Tumbarello M; Losito AR; Foti G; Prestileo T; Buscemi C; Chiara I; Iacobello C; Sonia S; Starnini G; Ialungo A; Sapienza M;
J Chemother; 2019 Feb; 31(1):9-14. PubMed ID: 30508410
[TBL] [Abstract][Full Text] [Related]
44.
Ioannou P; Vorria A; Samonis G
Antibiotics (Basel); 2024 Jun; 13(6):. PubMed ID: 38927228
[No Abstract] [Full Text] [Related]
45. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
46. Antibiotic susceptibility and genomic variations in Staphylococcus aureus associated with Skin and Soft Tissue Infection (SSTI) disease groups.
Changchien CH; Chen SW; Chen YY; Chu C
BMC Infect Dis; 2016 Jun; 16():276. PubMed ID: 27287530
[TBL] [Abstract][Full Text] [Related]
47. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management.
Maki DG; Agger WA
Medicine (Baltimore); 1988 Jul; 67(4):248-69. PubMed ID: 3134590
[TBL] [Abstract][Full Text] [Related]
48. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
49. Morphology engineering for enhanced production of medium-chain-length polyhydroxyalkanoates in Pseudomonas mendocina NK-01.
Zhao F; Gong T; Liu X; Fan X; Huang R; Ma T; Wang S; Gao W; Yang C
Appl Microbiol Biotechnol; 2019 Feb; 103(4):1713-1724. PubMed ID: 30610286
[TBL] [Abstract][Full Text] [Related]
50. Influence of carbon source on pyrimidine synthesis in Pseudomonas mendocina.
Santiago MF; West TP
J Basic Microbiol; 2003; 43(6):534-8. PubMed ID: 14625904
[TBL] [Abstract][Full Text] [Related]
51. [A case of Pseudomonas mendocina endocarditis].
Suel P; Martin P; Berthelot G; Robaday S; Etienne M; Chibani A
Med Mal Infect; 2011 Feb; 41(2):109-10. PubMed ID: 21094007
[No Abstract] [Full Text] [Related]
52. Review of meta-analyses of vancomycin compared with new treatments for Gram-positive skin and soft-tissue infections: Are we any clearer?
Tsoulas C; Nathwani D
Int J Antimicrob Agents; 2015 Jul; 46(1):1-7. PubMed ID: 25982913
[TBL] [Abstract][Full Text] [Related]
53. Pseudomonas oryzihabitans: an unusual cause of skin and soft tissue infection.
Tena D; Fernández C
Infect Dis (Lond); 2015; 47(11):820-4. PubMed ID: 26179756
[TBL] [Abstract][Full Text] [Related]
54. Unusually virulent coagulase-negative Staphylococcus lugdunensis is frequently associated with infective endocarditis: a Waikato series of patients.
Liang M; Mansell C; Wade C; Fisher R; Devlin G
N Z Med J; 2012 May; 125(1354):51-9. PubMed ID: 22595924
[TBL] [Abstract][Full Text] [Related]
55. Causative agents and antimicrobial resistance patterns of human skin and soft tissue infections in Bagamoyo, Tanzania.
Kazimoto T; Abdulla S; Bategereza L; Juma O; Mhimbira F; Weisser M; Utzinger J; von Müller L; Becker SL
Acta Trop; 2018 Oct; 186():102-106. PubMed ID: 30006029
[TBL] [Abstract][Full Text] [Related]
56. Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment.
Cardona AF; Wilson SE
Clin Infect Dis; 2015 Sep; 61 Suppl 2():S69-78. PubMed ID: 26316560
[TBL] [Abstract][Full Text] [Related]
57. Aerobic Biodegradation of OCDD by
Lin JL; Lin WC; Liu JK; Surampalli RY; Zhang TC; Kao CM
Water Environ Res; 2017 Dec; 89(12):2113-2121. PubMed ID: 29166993
[TBL] [Abstract][Full Text] [Related]
58. The isolation and functional identification on producing cellulase of Pseudomonas mendocina.
Zhang J; Hou H; Chen G; Wang S; Zhang J
Bioengineered; 2016 Sep; 7(5):382-391. PubMed ID: 27710430
[TBL] [Abstract][Full Text] [Related]
59. Infections with Pseudomonas paucimobilis: report of four cases and review.
Reina J; Bassa A; Llompart I; Portela D; Borrell N
Rev Infect Dis; 1991; 13(6):1072-6. PubMed ID: 1775840
[TBL] [Abstract][Full Text] [Related]
60. Regulation of pyrimidine synthesis in Pseudomonas mendocina.
Santiago MF; West TP
J Basic Microbiol; 2002; 42(1):75-9. PubMed ID: 11925763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
